Empathic Communication Skills (ECS) Training
Sponsor: Memorial Sloan Kettering Cancer Center • ClinicalTrials.gov ID: NCT05456841
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
Interventions
-
Empathic Communication Skills (ECS) training
(Behavioral)
The overall training goal of this 2.25 hour module ECS module is to enhance OCP recognition and responsiveness to lung cancer patients' empathic opportunities by communicating understanding, alleviating stigma and distress, and providing support. The ECS training also provides tools to OCPs to buffer/inoculate patients against stigmatizing attitudes and behaviors by others such that lung cancer patients who currently or formerly smoked can be given "small doses" of an opposing viewpoint (termed as "preparing patients for recurring smoking questions") and suggestions of "counterarguments" in order to make them resistant to future stigmatizing attacks by others
-
Standard of Care participant interaction
(Other)
Standard of Care participant interaction
Eligibility criteria
Conditions
Locations
- Providence St. Joseph Health (Data Collection Only) — Irvine, California, United States
- BAPTIST ALLIANCE - MCI (Data Collection Only) — Miami, Florida, United States
- Advocate Health Care Network — Libertyville, Illinois, United States
- University of Kentucky (Data Collection Only) — Lexington, Kentucky, United States
- Munson Healthcare (Data Collection Only) — Traverse City, Michigan, United States
- Hackensack Meridian Health (Data collection only) — Hackensack, New Jersey, United States
- Roswell Park Cancer Institute (Data Collection Only) — Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States
- Virtua Health (Data Collection Only) — Philadelphia, Pennsylvania, United States
- University of Pennsylvania (Data Collection Only) — Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center (Data Collection Only) — Philadelphia, Pennsylvania, United States
- Chesapeake Regional Healthcare (Data Collection Only) — Chesapeake, Virginia, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record